Robert Spiegel

Robert Spiegel

Directeur/Membre du Conseil chez GERON CORPORATION

Fortune : 385 754 $ au 31/08/2026

76 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Robert J.
Spiegel, MD, is an Independent Director at RenovoRx, Inc., an Independent Director at Ayala Pharmaceuticals, Inc., an Independent Non-Executive Director at Sun Pharma Advanced Research Co. Ltd., a Venture Advisor at Israel Biotech Fund, an Associate Professor at Weill Cornell Medical College, an Independent Director at Geron Corp., an Advisor at Warburg Pincus & Company US LLC, a President at Spiegel Consultants, LLC and a Member at Blood Cancer United, Inc. He is on the Board of Directors at Ernexa Therapeutics, Inc., RenovoRx, Inc., Ayala Pharmaceuticals, Inc., Sun Pharma Advanced Research Co. Ltd., Geron Corp.
and Oncology Clinical Research & Development.
Dr. Spiegel was previously employed as an Independent Director by Athenex, Inc., a Vice Chairman by Cyclacel Pharmaceuticals, Inc., an Independent Director by Ayala Pharmaceuticals, Inc. /Old/, an Independent Director by Sucampo Pharmaceuticals LLC, an Independent Director by Edge Therapeutics, Inc., an Independent Director by Weifa ASA, a Chief Medical Officer by PTC Therapeutics, Inc., an Independent Director by Talon Therapeutics, Inc., an Independent Director by Capstone Therapeutics Corp., a Chief Medical Officer by Schering-Plough Research Institute, a Director-Developmental Therapeutics by New York University Medical Center, a Chairman by NexImmune, Inc., a Vice President-Clinical Research by Schering-Plough Corp.
USA, and a Chief Medical Officer & Senior Vice President by Worldwide Clinical Research, Inc. He also served on the board at Advaxis, Inc., Vidac Pharma Ltd., PDS Biotechnology Corp., Avior Computing Corp., Rutgers Cancer Institute of New Jersey, CancerCare of New Jersey and NexImmune, Inc. He received his undergraduate degree from Yale University and a doctorate degree from the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2026 205 810 ( 0,03% ) 306 657 $ 31/08/2026
15/04/2026 40 983 ( 0,09% ) 79 097 $ 31/08/2026

Postes actifs de Robert Spiegel

SociétésPosteDébut
GERON CORPORATION Directeur/Membre du Conseil 21/05/2010
AYALA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2023
RENOVORX, INC. Directeur/Membre du Conseil 25/04/2023
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED Directeur/Membre du Conseil 01/06/2020
ERNEXA THERAPEUTICS INC. Directeur/Membre du Conseil 14/09/2026
Consultant / Advisor 01/01/2010
Oncology Clinical Research & Development
Directeur/Membre du Conseil -
Corporate Officer/Principal -
Consultant / Advisor 01/01/2015
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Robert Spiegel

SociétésPosteFin
░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Robert Spiegel

Formation de Robert Spiegel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

33

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées33

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Oncology Clinical Research & Development

CancerCare of New Jersey

Commercial Services

Finance

Spiegel Consultants, LLC

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Robert Spiegel
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT